Skip to main content
. 2021 Apr 15;11:603596. doi: 10.3389/fphar.2020.603596

FIGURE 1.

FIGURE 1

BHB prevents doxorubicin-induced left ventricular dysfunction. (A) Ejection fraction (EF); (B) fractional shortening (FS); (C) left ventricular diastolic internal dimension (LVIDd); (D) and left ventricular systolic internal dimension (LVIDs) among sham, DOX and DOX + BHB groups; (F) the presentative echocardiography images among groups. Each group had 5 mice. ##p < 0.01, ###p < 0.001 vs. Sham. **p < 0.01 vs. DOX group. n. s, not significant.